Track Record
Professionalism.  Persistence.  Performance.

Plexus Ventures has concluded transactions valued at more than $3 billion for our clients. We have successfully completed deals with most of the global pharmaceutical companies including Novartis, Pfizer, Lilly, GSK, Merck, Sanofi-Aventis, Johnson & Johnson, Bristol-Myers Squibb, and AstraZeneca.

During more than 25 years of serving clients, Plexus Ventures has achieved global recognition among pharmaceutical industry companies for its professionalism, persistence, and performance in achieving clients' objectives.

Each of our engagements is as unique as the objectives of our clients. 

Take a look at representative cases within each of our business development offerings:

In-Licensing Out-Licensing Acquisitions Divestments